Cellebrite (CLBT) Jumps 20.7% on Stellar Q3
In an updated report, Cellebrite DI Ltd. (NASDAQ:CLBT) said it swung to a net income of $20.19 million from a $207 million net loss in the same period last year.
Cellebrite Di Ltd. (CLBT)
Market is closed
Sector: Services-Prepackaged Software
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Pertento Partners Ian Trundle | 4,648,215 | $86,131,424 | +58% | 9.99% |
| 2. | Voss Capital Travis Cocke | 5,150,000 | $82,400,000 | 5.68% | |
| 3. | Renaissance Technologies Jim Simons | 2,902,105 | $53,776,006 | +9% | 0.07% |
| 4. | Nine Ten Partners Brian Bares, Russell Mollen, And James Bradshaw | 2,479,727 | $45,949,000 | +17% | 11.84% |
| 5. | Portolan Capital Management George Mccabe | 2,419,662 | $44,836,337 | +140% | 2.43% |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 13,861,007 | $256,844,460 | 94.16% | |
| 2. | 6,060,856 | $112,307,660 | 0.01% | |
| 3. | 5,560,196 | $103,030,432 | 0.02% | |
| 4. | 3,731,544 | $69,145,509 | 0% | |
| 5. | 2,507,096 | $46,457,623 | 0.56% |
News See All
Cellebrite DI Ltd. (NASDAQ:CLBT) Q3 2025 Earnings Call Transcript
Operator: Thank you for your continued patience. Your meeting will begin shortly. A member of our team will be happy to help you. Please stand by. Your program is about to begin.
Here’s Greenhaven Road Capital’s Views on Cellebrite (CLBT)
Greenhaven Road Capital, an investment management company, released its third-quarter 2025 investor letter. A copy of the letter can be downloaded here.
Cellebrite DI Ltd. (CLBT): A Bull Case Theory
We came across a bullish thesis on Cellebrite DI Ltd. on Value investing subreddit by BoredSuzuki. In this article, we will summarize the bulls’ thesis on CLBT.
\What Makes Cellebrite DI Ltd. (CLBT) a Lucrative Investment?
ClearBridge Investments, an investment management company, released its “ClearBridge Small Cap Growth Strategy” third-quarter 2025 investor letter. A copy of the letter can be downloaded here.
Is Cellebrite (CLBT) Poised to Re-Accelerate in 2026?
Voss Capital, LLC, an investment management company, released its second-quarter 2025 investor letter. A copy of the letter can be downloaded here.
Craig-Hallum Reiterates a Buy Rating on Cellebrite DI Ltd. (CLBT)
Cellebrite DI Ltd. (NASDAQ:CLBT) is one of the best stocks under $20 to buy for the long term. On August 19, Craig-Hallum analyst Jeff Van Rhee maintained a Buy rating on Cellebrite DI Ltd.
10 Best Stocks Under $20 to Buy for the Long Term
On August 22, Manpreet Gill of Standard Chartered Wealth Management appeared on CNBC, stating that he sees a cut in the Federal Reserve’s upcoming September meeting and that it’s time to “lock in...
Cellebrite (CLBT) Fell Due to Below-Expected Outlook, but Core Trends Persist
Carillon Tower Advisers, an investment management company, released its “Carillon Eagle Small Cap Growth Fund” second-quarter 2025 investor letter. A copy of the letter can be downloaded here.
Cellebrite (CLBT) Fell on Investors' Worry that US Federal Budget Uncertainty Could Delay Purchases
Greenhaven Road Capital, an investment management company, released its second-quarter 2025 investor letter. A copy of the letter can be downloaded here. A copy of the letter can be downloaded here.
Hedge Fund Resource Center Billionaire Hedge Funds
